What Are IPO Valuation Methods? A Deep Dive into Investment Bank Pricing Models

The Hong Kong IPO market in 2025 is no longer a venue where a growth narrative alone commands a 30x price-to-earnings (P/E) multiple. Following the HKEX’s introduction of Chapter 18C for Specialist Technology Companies in March 2023 and the subsequent surge in GEM reform listings in 2024, the divergence between book-building demand and aftermarket performance has reached a five-year high. According to Deloitte’s 2025 Hong Kong IPO market review, the average first-day pop for new listings in Q1 2025 was 8.4%, down from 14.2% in the same period of 2023, while the average discount to the final offer price on the first day of trading widened to 2.1%. This compression forces a critical question for sponsors, analysts, and CFOs: which valuation methodology actually drives the final placing price, and which is merely window dressing for the prospectus. The answer determines whether a family office commits USD 5 million to a cornerstone tranche or sits on the sidelines. This article dissects the three primary models—discounted cash flow (DCF), comparable company analysis (comps), and precedent transactions—as they are applied in Hong Kong’s regulatory framework, citing specific HKEX Listing Rules and SFC codes that govern price discovery.

The DCF Model: Theoretical Anchor or Regulatory Necessity?

The discounted cash flow (DCF) model remains the most technically rigorous method for valuing pre-profit biotech and specialist technology companies under HKEX Chapter 18A and 18C. However, its output is rarely the sole determinant of the final offer price. The SFC’s Code of Conduct for Persons Licensed by or Registered with the Securities and Futures Commission (the SFC Code), paragraph 5.2, requires sponsors to ensure that any valuation included in a prospectus is “fair and reasonable” and based on “reasonable assumptions.” In practice, this means the DCF must be defensible under cross-examination by the Listing Division, but it often serves as a floor rather than a ceiling.

Revenue Growth Assumptions and Terminal Value Sensitivity

For a 2025 IPO candidate in the AI infrastructure space, a typical DCF model might assume a 5-year revenue CAGR of 35%, tapering to a terminal growth rate of 3.0% (consistent with Hong Kong’s long-term GDP trend). A 100-basis-point change in the terminal growth rate alters the enterprise value by approximately 12-15% for a company with a 15% free cash flow margin. The HKEX Listing Decision LD143-2019 (re: Profit Forecasts) explicitly warns against “overly optimistic growth projections” that cannot be supported by historical data or independent market research. Sponsors are now required to include a sensitivity table showing EV changes across a range of WACC (weighted average cost of capital) from 8.0% to 14.0%, a direct response to the 2023-2024 interest rate cycle that saw the HKMA base rate peak at 5.75%.

The WACC Debate: Hong Kong Risk Premium vs. Global Benchmarks

The cost of equity calculation for a Hong Kong-listed company often uses a risk-free rate derived from the 10-year HKD Exchange Fund Notes (currently ~3.8% as of April 2025) plus an equity risk premium (ERP) of 6.5% to 7.5% for mid-cap companies. This contrasts with a US-listed comparable, which might use a 10-year UST yield of 4.2% and a lower ERP of 5.0%. The resulting WACC differential—often 200-300 bps higher for Hong Kong issuers—directly depresses the DCF valuation. The SFC’s 2024 consultation on IPO price formation (concluded in February 2025) noted that sponsors must disclose any jurisdiction-specific risk premium adjustments in the “Basis of Opinion” section of the sponsor’s report, a requirement codified in the revised SFC Code paragraph 17.7.

Comparable Company Analysis (Comps): The Market’s Arbitrage Tool

Comparable company analysis is the most frequently cited valuation method in Hong Kong IPO prospectuses, particularly for Main Board listings of consumer, industrial, and financial firms. The HKEX Listing Rules, specifically Rule 11.07, require that the offer price be “determined by reference to the market price of comparable listed companies.” In practice, comps are used to calibrate the price range, with the final price set via book-building.

Multiples Selection and the “Hong Kong Discount”

The standard set of multiples includes trailing P/E, forward P/E, EV/EBITDA, and price-to-book (P/B). For a 2025 consumer goods IPO, a sponsor might select a peer group of 8-12 Hong Kong-listed companies with similar revenue scale (HKD 500 million to HKD 2 billion) and growth rates. The median forward P/E for this group might be 12.5x. However, the final offer price for the IPO is typically set at a 10-20% discount to this median, a phenomenon known in the market as the “Hong Kong discount.” Data from the HKEX’s 2024 IPO report shows that 73% of new listings on the Main Board were priced below the midpoint of the book-building range, with an average discount of 15.3% to the median comp multiple. This discount compensates for liquidity risk (average daily turnover of HKD 10 million or less for 60% of new listings) and the absence of a proven track record as a listed entity.

The Role of Pre-IPO Round Pricing

A critical but often overlooked input is the price of the most recent pre-IPO funding round. Under HKEX Listing Rule 9.11(24a), the sponsor must disclose any “material difference” between the offer price and the price paid by pre-IPO investors within the 12 months prior to listing. If the pre-IPO round was priced at a 30% discount to the comps-derived range, the sponsor must justify the increase, typically by citing revenue growth or a de-risked business model. This creates a hard floor: the offer price cannot fall below the pre-IPO price without triggering a “down round” stigma, which the SFC views as a red flag for price manipulation under the Securities and Futures Ordinance (Cap. 571), Section 300.

Precedent Transactions: The Liquidity Event Benchmark

Precedent transaction analysis values the IPO company by reference to M&A multiples in the same sector. This method is most relevant for companies with a clear exit strategy or for SPAC de-SPAC transactions, which have seen a resurgence in Hong Kong following the HKEX’s introduction of SPAC rules in January 2022 (Chapter 18B).

Control Premium vs. Minority Discount

A precedent transaction typically includes a control premium of 25-40% over the pre-announcement trading price of the target. For an IPO, which is a minority stake sale (usually 15-25% of the enlarged share capital), the sponsor must apply a minority discount to the precedent transaction multiple. The SFC’s 2023 guidance on valuation methodology (circular dated 15 June 2023) explicitly states that “the use of precedent transactions without adjustment for the lack of control and lack of marketability is not acceptable.” A typical adjustment might reduce the EV/EBITDA multiple from 14.0x (the transaction multiple) to 10.5x (the IPO multiple), a 25% haircut.

Sector-Specific Precedent Sets: The Case of 2024-2025 IPOs

For a 2025 IPO in the logistics sector, the precedent set might include the 2024 acquisition of a Hong Kong-based logistics firm by a mainland Chinese conglomerate at 12.0x EV/EBITDA, and the 2025 merger of two regional players at 10.5x EV/EBITDA. The sponsor would then argue that the IPO company, with a 15% EBITDA margin versus the peer average of 12%, deserves a multiple at the higher end of the range—say 11.5x. However, the HKEX Listing Division often challenges this by requiring the sponsor to demonstrate that the transaction comparables are “sufficiently similar in size, geography, and business model,” per the guidance in LD145-2020. If the precedent transactions involved companies with HKD 1 billion in revenue and the IPO candidate has only HKD 200 million, the multiple must be scaled down.

The Book-Building Process: Where Models Meet Market Reality

The three valuation methods produce a range—for example, DCF at HKD 15.00-18.00 per share, comps at HKD 16.00-20.00, and precedent transactions at HKD 17.00-22.00. The sponsor then sets an initial price range, typically HKD 16.00-20.00, and submits it to the HKEX for approval. The book-building process, governed by the SFC’s Code of Conduct for Share Offerings, then determines the final price.

Anchor Orders and Price Discovery

Institutional investors—primarily long-only funds, hedge funds, and family offices—submit bids with price and volume limits. The HKEX’s electronic IPO allocation system, introduced in 2024, allows for real-time visibility of the book. If anchor orders (typically 60-70% of the institutional tranche) are clustered at HKD 17.00, the sponsor will price at or near that level. The final offer price is set such that the institutional book is 2-3x oversubscribed, a heuristic that balances demand with the risk of a post-listing decline. Data from the 2024 HKEX Annual Report shows that IPOs with an institutional oversubscription ratio below 2.0x had an average first-day decline of 3.2%, while those above 5.0x had an average gain of 11.1%.

The “Greenshoe” and Price Stabilisation

The over-allotment option (Greenshoe), permitted under HKEX Listing Rule 10.08, allows the stabilising manager to purchase up to 15% of the offer size at the offer price to support the stock in the first 30 days. The valuation models directly inform the Greenshoe size: if the DCF-derived floor is HKD 15.00 and the offer price is HKD 18.00, the stabilising manager has a 16.7% cushion before the stock trades below intrinsic value. If the comps-derived fair value is HKD 17.00, the cushion narrows to 5.6%, increasing the likelihood of active intervention. The SFC’s Code of Conduct, paragraph 8.2, requires the stabilising manager to disclose all trades, ensuring that the price floor is not artificially inflated.

Closing: Five Actionable Takeaways

1. For CFOs: The DCF model is your regulatory shield—ensure the sensitivity analysis covers a WACC range of 8.0% to 14.0% and includes a terminal growth rate no higher than 3.0% to satisfy HKEX Listing Decision LD143-2019.
2. For IBD analysts: The comps-derived discount to the median peer multiple should be no less than 10% for a Main Board listing, and the pre-IPO round price must be disclosed if it occurred within 12 months, per Listing Rule 9.11(24a).
3. For family office investors: A final offer price set at the top of the range with an institutional book oversubscription below 2.0x signals a 3.2% average first-day decline—avoid the allocation unless you have a 6-month holding period.
4. For sponsors: The precedent transaction multiple must be adjusted by a minority discount of at least 25% and supported by a geographic and size comparability table, as required by the SFC’s 2023 valuation circular.
5. For all market participants: Monitor the HKEX’s electronic IPO allocation system data for real-time bid clustering—a 60% anchor order concentration at a single price point is the strongest signal of the final offer price.